迟发性运动障碍

chí fā xìnɡ yùn dònɡ zhànɡ ài
  • tardive dyskinesia
迟发性运动障碍迟发性运动障碍
  1. 目的观察维生素E(VitE)对迟发性运动障碍(TD)大鼠的影响,探讨TD可能的病理生理机制。

    Objective To investigate pathophysiological mechanism of tardive dyskinesia ( TD ) by treating the TD model rats with Vitamin E ( Vit E ) .

  2. 调查33例双相情感性精神障碍患者迟发性运动障碍(TD)有关的因素,并评估其认知功能。

    Objective : To investigate the risk factors associated with tardive dyskinesia ( TD ) in patients with bipolar affective disorder .

  3. 方法:采用异常不自主运动量表(AIMS)评分,对23例住院的迟发性运动障碍患者进行12年随访。

    Method : 23 patients with TD had been followed up for 12 years , and assessed with AIMS .

  4. 迟发性运动障碍患者超氧化物歧化酶、ATP酶活性改变

    The activation of SOD and ATP in schizophrenic patients with tardive dyskinesia

  5. 目的:调查撤药出现的运动障碍(WE-D)是否为迟发性运动障碍(TD)的早期征象。

    Objective : To investigate whether withdrawal emergent dyskinesia ( WE D ) is the early signal of tardive dyskinesia ( TD ) .

  6. 目的:探讨伴有迟发性运动障碍(TD)的精神分裂症患者血清铁指数(血清铁含量、铁结合力和铁蛋白)。

    Objective : To investigate the serum iron indices ( iron , total iron binding capacity and ferritin ) in the schizophrenia with tardive dyskinesia .

  7. 结论COMT基因Val158Met多态性与迟发性运动障碍易感性之间不存在关联,但可能与男性TD患者的症状严重程度相关。

    Conclusion COMT gene Val158 / 108Met polymorphism is not associated with susceptibility to TD , but is probably related to TD severity in male TD patients .

  8. 目的:对比迟发性运动障碍(TD)、非TD(TD-)精神分裂症患者、正常对照血清泌乳素(PRL)水平,探索TD可能的病理生理机制。

    Objective : To investigate pathophysiological mechanism of tardive dyskinesia ( TD ) by comparing the level of serum prolactin ( PRL ) of schizophrenic patients with TD to that of patients without TD ( TD - ) and normal volunteers .

  9. 丙戊酸钠治疗迟发性运动障碍的双盲对照研究

    A double-blind comparative study of sodium valproate in treating of TD

  10. 迟发性运动障碍患者血清泌乳素浓度分析

    The Serum Concentration of Prolactin in Schizophrenic Patients with Tardive Dyskinesia

  11. 柴胡桃仁汤对迟发性运动障碍的治疗及可能机制

    Effect of Chaihu-Taoren Tang on tardive dyskinesia and the possible mechanism

  12. 迟发性运动障碍患者的血清铁指数研究

    Study of serum iron indices in patients with tardive dyskinesia

  13. 对慢性精神病人迟发性运动障碍的调查

    A Survey on TD of Patients with Chronic Mental Diseases

  14. 迟发性运动障碍12年随访报告

    A 12 years follow up study on tardive dyskinesia

  15. 多巴胺转运体基因与迟发性运动障碍的关联性

    An association study between dopamine transporter gene and tardive dyskinesia in schizophrenic patients

  16. 氟苯桂嗪治疗迟发性运动障碍的双盲自身对照试验

    A Double-Blind Trial of Flunarizine Therapy for Tardive Dyskinesia

  17. Ⅰ型、Ⅱ型精神分裂症迟发性运动障碍调查分析

    Analysis of Tardive Dyskinesia in Type ⅰ、ⅱ schizophrenics

  18. 褪黑素治疗伴有迟发性运动障碍认知功能对照研究

    Melatonin in treatment of schizophrenia with tardive dyskinesia : A comparison study of cognitive function

  19. 氯硝西泮治疗持续性迟发性运动障碍

    Persistent Tardive Dyskinesia Treated with Clonazepam

  20. 我们仅仅通过对大鼠施用神经松驰剂,就搞出了一个迟发性运动障碍的实验动物模型。

    We developed an experimental animal model of tardive dyskinesia simply by treating rats with neuroleptics .

  21. 锰超氧化物歧化酶功能基因多态性及酶活性与迟发性运动障碍的关系

    Relationship of manganese superoxide dismutase gene polymorphism and the enzyme activity in plasma with tardive dyskinesia in schizophrenia

  22. 抗精神病药所致迟发性运动障碍患者血浆超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性及丙二醛浓度的改变

    The changes of plasma superoxide dismutase , catalase , glutathione peroxidase , maleic dialdehyde in patients with antipsychotics-induced tardive dyskinesia

  23. 这张嘴的动作是没病却吃称为“迟发性运动障碍”的精神病药物的副作用。

    The mouth movements are a side effect ( not the actual condition ) of taking antipsychotic meds , which is called tardive dyskinesia .

  24. 抗精神病药物导致的迟发性锥体外系综合征(TES)由迟发性运动障碍(TD)发展而来。

    Neuroleptic - associated tardive extrapyramidal syndrome ( TES ) has been developed in the base of the tardive dyskinesia ( TD ) .